The Cannabis ETF (THCX)
ARCA ARCA Primary 
The Biden Administration's Latest Move Makes This Cannabis Stock a Buy
The Biden Administration is rescheduling cannabis from Schedule I to Schedule III, relieving a major tax burden currently affecting the cannabis industry. Green Thumb Industries is one of the few major U.S. operators that has made a profit in the last few years.
Top Cannabis Penny Stocks to Consider in June
The cannabis industry continues to thrive in 2024, making marijuana stocks a hot topic for investors. With the U.S. market valued at $30 billion and projected to reach $50 billion by 2028, there's immense growth potential. Ancillary companies, which provide essential services and products to the cannabis sector, are also gaining traction. These companies, from packaging suppliers to technology firms, are crucial for the industry's infrastructure. Recently, headlines have been dominated by discussions of federal legalization, which could open new markets and streamline operations. This regulatory shift could further boost stock values, making it a pivotal time to consider marijuana penny stocks.
3 Sorry Cannabis Stocks to Sell in May While You Still Can
Recently, the cannabis market received the best hoped-for news. The Drug Enforcement Administration (DEA) announced it is moving forward with plans to reschedule marijuana from a Schedule I to a Schedule III controlled substance.
Schedule III Windfall: 3 Stocks to Buy BEORE the Cannabis Reclassification
I have talked about cannabis stocks to buy in several instances in the last few quarters. However, the timing for exposure couldn't be better than now for several reasons.
Cannabis Bargains: 3 Underappreciated Stocks to Snap Up in May 2024
As the cannabis industry evolves, its economic contributions could climb dramatically, offering ample growth opportunities for underappreciated cannabis stocks. Cannabis stocks have skyrocketed on the U.S. Department of Justice's plan to reschedule marijuana as a less risky Schedule III drug.
The 2024 Millionaire's Club: 7 Cannabis Stocks to Buy Now
One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. We can see that with more than 88% of Americans wanting to see legalization.
3 Cannabis Stocks to Buy Now: May 2024
Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the status of cannabis stocks as a whole. Cannabis stocks, as a whole, spiked upwards on the news but quickly reverted to pre-announcement norms.
Marijuana Stocks For Today's Cannabis Investor
Some marijuana stocks are continuing their volatile fluctuation in the market. As many know the uncertainty of laws and better regulations create the bulk of the volatile trading. Still, there has been a great deal of success both in and out of the stock market. Now with some pot stocks taking a slight downtrend, this could be a time to invest. When there is a price drop this is where many would begin looking for the best marijuana stocks to buy. When a volatile downtrend occurs you can never be too sure when the next uptrend will be.
Weed Out the Weak: 3 Choking Cannabis Stocks to Cut Now
Investors should not get overly excited about President Biden's decision to reclassify marijuana. The potential move toward becoming a less dangerous schedule 3 drug is lengthy and will not result in cannabis becoming federally legal.
Cannabis companies continue federal legalization push despite marijuana's rescheduling
A federal lawsuit challenging nationwide restrictions on marijuana will continue despite a proposal by the U.S. government to lower the classification of cannabis to a less dangerous level of Schedule III, the lead lawyer for the case said Wednesday.
3 Cannabis Stocks That Could Be Millionaire-Makers: May Edition
Cannabis stocks to buy are rallying after the U.S. Department of Justice proposed reclassifying marijuana as a less risky Schedule III drug. Following the DOJ's proposal, President Biden came out on X, commending the move while signaling a rosier future for cannabis stocks.
Cannabis Investing Masterclass With Julian Lin + Jerry Derevyanny
Are some cannabis companies massaging earnings results, using metrics like cash flow from operations and free cash flow to present a positive financial picture? Jerry Derevyanny and Julian Lin on why investors should be cautious and look deeper into financial metrics.
